CEACAM5 and neoplasm: There were no significant differences between the two groups with regard to age, body mass index, ASA classification, preoperative serum CEA levels, tumor location, pT, pN, pStage, neo-CRT, histopathological type, tumor diameter, and adjuvant chemotherapy.